Educate. We’re Serious About the Science.

Weizmann Institute
of Science

The Weizmann Institute of Science is one of the world’s leading multidisciplinary research institutions, located in Rehovot, Israel. Guided by its mission of science for the benefit of humanity, Weizmann’s scientific community engages in research addressing crucial problems in medicine and health, energy, technology, agriculture, and the environment. Breast cancer has long been a key area of investigation on campus, where more than 50 research groups focus on fighting cancer. Whether seeking the origins of breast cancer, targeting particular types, or creating new ways to treat and diagnose the disease, Weizmann scientists are committed to improving breast-cancer outcomes. As advocates for those who face this all-too-common cancer, we at Learn Look Locate are dedicated to supporting and raising awareness of the Weizmann Institute’s vital, groundbreaking work.

Why We Support the Weizmann Institute of Science?

Learn Look Locate feels strongly that more funding needs to be focused on basic science research to understand and stop cancer so we are dedicated to supporting the Weizmann Institute of Science. We will contribute to the amazing research that the incredible scientists at the Weizmann Institute are doing to accomplish this goal. This page is dedicated to the acknowledgement of the on-going extensive research efforts being done by the Weizmann Institute.

Dr. Ravid Straussman

Department of Molecular Cell Biology

Prof. Hadassa Degani

Department of Biological Regulation

Prof. Sima Lev

Department of Molecular Cell Biology

Prof. Yosef Yarden

Department of Biological Regulation

Dr. Ravid Straussman

Department of Molecular Cell Biology

Prof. Hadassa Degani

Department of Biological Regulation

Prof. Sima Lev

Department of Molecular Cell Biology

Prof. Yosef Yarden

Department of Biological Regulation

I am so honored and excited to launch this very important page on my website featuring The Weizmann Institute of Science. They are one of the world’s leading multidisciplinary research institutions, located in Rehovot, Israel. Guided by its mission of science for the benefit of humanity, Weizmann’s scientific community engages in research addressing crucial problems in medicine and health, energy, technology, agriculture, and the environment. Breast cancer has long been a key area of investigation on campus, where more than 50 research groups focus on fighting cancer. Whether seeking the origins of breast cancer, targeting particular types, or creating new ways to treat and diagnose the disease, Weizmann scientists are committed to improving breast- cancer outcomes. As advocates for those who face this all-too-common cancer, we at Learn Look Locate are dedicated to supporting and raising awareness of the Weizmann Institute’s vital, groundbreaking work. Learn more.

Dr. Ravid Straussman

Department of Molecular Cell Biology

Bacteria in Tumors Dr. Ravid Straussman is creating methods that make it possible to carefully characterize and visualize the bacteria inside human tumors, thus helping to determine their role in chemotherapy resistance. This research may reveal new bacteria-based biomarkers capable of helping doctors create personalized chemotherapy protocols for breast cancer and other malignancies based on a tumor’s bacterial profile.

Prof. Hadassa Degani

Department of Biological Regulation

Improving MRI-Based Cancer Imaging Prof. Hadassah Degani developed a technique that improves the usefulness of MRI for breast cancer diagnosis. The method reduces the need for invasive biopsies, while providing clinicians with a better understanding of the effectiveness of specific drug treatments.

Prof. Sima Lev

Department of Molecular Cell Biology

Proteins and Drug Targets in Triple Negative Breast Cancer Prof. Sima Lev is studying the role of a number of proteins that are involved in triple negative breast cancer (TNBC), a highly aggressive subtype of the disease that primarily affects younger women and has no known cure. Her integrated research may help identify new therapeutic targets for drug design and create new strategies for the successful treatment of this devastating form of breast cancer.

Prof. Yosef Yarden

Department of Biological Regulation

Molecular Dynamics of Breast Cancer Metastasis Prof. Yosef Yarden identified a previously unknown dynamic that promotes metastatic cell migration, a fundamental characteristic of aggressive breast cancer. This discovery may eventually lead to new clinical strategies designed to “short circuit” a key signaling process and slow the spread of cancer

“This page is dedicated to the on-going breast cancer research being done by the Weizmann Institute of Science.”

Educate. Inspire. Connect.

Join the global movement
* We value your privacy. View our Privacy Policy here.

Dr. Ravid Straussman

Department of Molecular Cell Biology

Bacteria in Tumors
Dr. Ravid Straussman is creating methods that make it possible to carefully characterize and visualize the bacteria inside human tumors, thus helping to determine their role in chemotherapy resistance. This research may reveal new bacteria-based biomarkers capable of helping doctors create personalized chemotherapy protocols for breast cancer and other malignancies based on a tumor’s bacterial profile.

Prof. Hadassa Degani

Department of Biological Regulation

Improving MRI-Based Cancer Imaging
Prof. Hadassah Degani developed a technique that improves the usefulness of MRI for breast cancer diagnosis. The method reduces the need for invasive biopsies, while providing clinicians with a better understanding of the effectiveness of specific drug treatments.

Prof. Sima Lev

Department of Molecular
Cell Biology

Proteins and Drug Targets in Triple Negative Breast Cancer
Prof. Sima Lev is studying the role of a number of proteins that are involved in triple negative breast cancer (TNBC), a highly aggressive subtype of the disease that primarily affects younger women and has no known cure. Her integrated research may help identify new therapeutic targets for drug design and create new strategies for the successful treatment of this devastating form of breast cancer.

Prof. Yosef Yarden

Department of Biological Regulation

Molecular Dynamics of Breast Cancer Metastasis
Prof. Yosef Yarden identified a previously unknown dynamic that promotes metastatic cell migration, a fundamental characteristic of aggressive breast cancer. This discovery may eventually lead to new clinical strategies designed to “short circuit” a key signaling process and slow the spread of cancer